Radiotherapy and Oncology

Article	Citations
Contents	142
Aims+Scope/Editorial Board/ Publication information	111
Radiation therapy and immigration status in women with breast cancer	103
Pioneering BNCT: Refining strategies for complex cutaneous malignancies	98
Pretreatment arterial spin labeling combined with radiological depth of invasion predicts treatment outcome in nonmetastatic NPC	91
Novel approaches to fiducial-guided SBRT for ultra-central thoracic oligometastases	89
Dose response relation for optic nerve atrophy at low-dose rate brachytherapy of uveal melanoma	86
Contents	85
The effect of coronary artery calcifications and radiotherapy on the risk of coronary artery disease in high-risk breast cancer patients in the DBCG RT-Nation cohort	80
Longitudinal changes in the carotid arteries of head and neck cancer patients following radiation therapy: Results from a prospective serial imaging biomarker characterization study	79
Aims+Scope/Editorial Board/ Publication information	73
Histology-driven hypofractionated radiation therapy schemes for early-stage lung adenocarcinoma and squamous cell carcinoma	71
Brachytherapy for rhabdomyosarcoma: Survey of international clinical practice and development of guidelines	71
In vivo validation and tissue sparing factor for acute damage of pencil beam scanning proton FLASH	70
A novel semi auto-segmentation method for accurate dose and NTCP evaluation in adaptive head and neck radiotherapy	69
OC-0102 DBCG phase III randomized trial of hypo- vs standard fractionated RT in 2879 pN+ breast cancer pts	63
Plan quality assessment in clinical practice: Results of the 2020 ESTRO survey on plan complexity and robustness	62
Clinical implementation of deep learning contour autosegmentation for prostate radiotherapy	60
The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients: Results of the REQUITE study	58
Online adaptive radiotherapy of urinary bladder cancer with full re-optimization to the anatomy of the day: Initial experience and dosimetric benefits	58
PD-0242 Comparison of static and dynamic proton arc treatment planning algorithms in oropharyngeal cancer	55
Dose response modelling of secretory cell loss in salivary glands using PSMA PET	55
X-ray on chip: Quantifying therapeutic synergies between radiotherapy and anticancer drugs using soft tissue sarcoma tumor spheroids	54
Response to “Comments on ‘Radiotherapy alone versus concurrent chemoradiotherapy in patients with stage II and T3N0 nasopharyngeal carcinoma with adverse features: A propensity score-matched cohort st	54
Assessment of gaze direction during head and neck irradiation and dosimetric impact on the retina, macula and papilla in a cohort of 240 patients with paraoptic tumors	50

Incidence of hippocampal and perihippocampal brain metastases and impact on hippocampal-avoiding radiotherapy: A systematic review and meta-analysis	49
Cardiovascular toxicities of radiotherapy: From practical issues to new perspectives	49
PO-1809 Treatment plan dose calculation using the novel HyperSight CBCT	48
Factors associated with acute esophagitis during radiation therapy for lung cancer	48
Combining rescanning and gating for a time-efficient treatment of mobile tumors using pencil beam scanning proton therapy	48
SP-0683 Combining immunotherapy with radiotherapy	48
PO-1668 An evaluation of a novel CBCT system: image quality, extended FoV and metal artefact reduction	47
Training and temporally validating an NTCP model of acute toxicity after whole breast radiotherapy, including the impact of advanced delivery techniques	46
Normal tissue complication probability model for acute oral mucositis in patients with head and neck cancer undergoing carbon ion radiation therapy based on dosimetry, radiomics, and dosiomics	46
Universal evaluation of MLC models in treatment planning systems based on a common set of dynamic tests	46
Ultra-fast pencil beam scanning proton therapy for locally advanced non-small-cell lung cancers: Field delivery within a single breath-hold	45
Definitive radiotherapy in patients with clinical T1N0M0 esophageal squamous cell carcinoma: A multicenter retrospective study (KROG 21–10)	44
Lymph drainage and cervical fascia anatomy-oriented differential nodal CTV delineation at the supraclavicular region for esophageal cancer and nasopharyngeal cancer	43
Long-term outcomes of ultra-hypofractionated 2 fractions single day HDR brachytherapy in localized prostate cancer	42
PO-0244 HDR brachytherapy monotherapy with 2 x 13.5 Gy for localized prostate cancer: short term follow up	41
Stereotactic radioablation of ventricular arrhythmias in patients with structural heart disease – A systematic review	41
1655: Radiation-induced T-lymphocyte Apoptosis and Prostate Radiotherapy: final data of the French trial	40
Evidence is not sufficient to declare the tubal gland conglomerates as salivary	40
A critical reflection of radiotherapy on osseous free flaps in mandibular segmental resection and immediate reconstruction in locally advanced oral squamous cell carcinoma: A cohort study	39
1353: Impact of VOLOTMUltra optimizer for Radixact system on treatment plan quality and efficiency	38
2225: Comparing the Hungarian RTT’s practice in the head and neck region with the ESTRO Guideline	38
Immunohistological profiling confirms salivary gland-like nature of the tubarial glands and suggests closest resemblance to the palatal salivary glands	38
Beam pulse structure and dose rate as determinants for the flash effect observed in zebrafish embryo	38
3235: Predictors of executive function decline after brain RT: a novel NTCP analysis	38
1299: Individualised isotoxic radiotherapy for re-irradiation in recurrent pelvic cancers	37
1748: Collimated active spot-scanning IMPT vs VMAT for lung SBRT: Dosimetric and robustness comparison	36
2724: Patient interchangeability between beam-matched accelerators	36
3007: SABR prior to liver transplantation in HCC patients: a 10 years’ experience	36
1676: Unexpected correlation between DWI and treatment response in HPV negative oropharyngeal carcinoma	35
2121: Should we switch to convolution algorithm when treating AVMs embolized with Onyx?	35
2489: Endothelial senescence primes aggressiveness of glioblastoma cells after radiotherapy	35
937: Prediction of the dose-averaged proton linear energy transfer using convolutional neural networks	35
2933: Utility of circulating tumor HPV DNA for oropharynx cancer treated at an urban medical center	35
749: Reinforcement learning for accelerated automatic treatment planning optimization	34
987: Pattern-of-Care Analysis for Radiotherapy of Cutaneous Lymphomas Among EORTC Members	34
1998: Automation of Dose Stability Test in Helical Irradiations on Tomotherapy linear accelerators	33
1045: Characterising spatial distribution of imaging parameters in cervical cancer	33
2172: Focused Ultrasound and RadioTHERapy for pain treatment in bone metastasis:an update of FURTHER trial	33
43: CPAP-assisted breathing and Supine Tangent Left Breast RT when DIBH-RT was Ineffective or Unsuitable	33
729: Development of an automatic deformable registration workflow for multi-modal prostate imaging	33
347: The impact of molecular classification on adjuvant radiotherapy choice for early endometrial cancer	32
438: Less pneumonia after nCRT and resection in oesophageal cancer using proton RT	32
893: The impact on overall survival of celiac plexus radiosurgery, post-hoc analysis of a clinical trial	31
2808: Off-line plan evaluation with CBCT-Synthesized-CT in patients treated with DIBH for left breast	31
480: Simulating radiotherapy induced skin reactions with moulage on all skin types, Phase 1 findings.	31
419: surgery versus radiotherapy for limited-stage small cell esophageal carcinoma: a multicenter study	31
1232: Modern era radical radiotherapy toxicity: a preliminary CONCORDE analysis of the calibration arm	31
360: The role of SGRT in detecting inter and intra fraction errors in SBRT treatments to the lung	31
2180: Outcomes of salvage prostate re-irradiation for local recurrence after definitive radiation therapy	30
2211: Investigation of chromosome aberration of different number of CBCT combined with therapeutic beams	30

1489: Impact of Cardiac Radiation Dose on Subclinical and Clinical Cardiotoxicity HER2+ Breast Cancer	30
2959: The Impact of Advanced Algorithms on the Treatment of Meningiomas	30
65: Accuracy of SGRT versus MV EPID-based ball bearing positions for clinical range of couch rotations	29
2177: Impact Metal Implants on Radiotherapy Planning: HU Value Variations with 80kV and 140kV Tube Voltage	29
3225: Commissioning of the Fricke solution dosimeter for particle therapy	29
2533: Evaluation of set-up uncertainty in Radiosurgery using ExacTrac for validation of PTV margins	29
330: External validation of rectal cancer CTV auto-contouring with patient-specific prior for online ART	29
2395: Local control and toxicity after upper abdominal SBRT with Simultaneous Integrated Protection (SIP)	29
443: In-situ recalibration of PTW STARCHECK detector array by measuring set of beam profiles	29
1254: Tumor Control Probability predictions for Hyperthermia plus Radiotherapy under varying conditions	28
452: Can 1 mm PTV margin be used for radiosurgery patients laying on wedges?	28
3138: Mediastinal irradiation for thymic epithelial tumors: A deep focus on coronary arteries’ exposure	28
2124: Respiratory gated planning of non-small cell lung cancer with new data-driven gated (DDG) PET/CT	28
1807: Deep learning-based dose prediction for breast and regional lymph node radiotherapy	28
2208: Implementing photobiomodulation as supportive care activity in an oncology-radiotherapy center	27
3310: Challenges and dilemmas in the elderly gynaecological cancer patient	27
2925: Urethral dosimetric implications of a multifocal MRI-based microboost in prostate robotic SBRT	27
2311: Treatment plan robustness in IMPT for esophageal cancer: every millimeter counts.	27
3314: Child-friendly on-treatment solutions (RTT perspective)	27
614: National guidelines for QA of deformable dose mapping: Feasibility and effect on dose prescription	27
560: Outcomes of stereotactic body radiotherapy on oligometastatic and oligoprogressive breast cancer	27
1787: MR-guided stereotactic ablative radiotherapy for central lung tumors: long-term clinical outcomes.	26
2219: Breaking boundaries: improve flow and create a positive work environment for radiation technologists	26
24: Experience on patient- specific QA for HyperArc stereotatic plans	26
154: Identifying the Continuous Professional Development Educational Needs of Belgian RTTs	26
3006: Clinical markers of altered Body image in Patients with Head and Neck cancers	26
2562: AI-enhanced proton radiography: deep learning for assessing treatment deviations in proton therapy	26
2310: The development of a UK curriculum for therapeutic radiographers at an advanced level of practice.	26
2997: Comprehensive cosmesis evaluation of ultrahypofractionated adjuvant breast radiotherapy with SIB	26
1586: Dose perturbation due to surgical clips and titanium mesh in proton therapy	26
938: Radiation-induced cerebral contrast enhancements strongly share ischemic stroke risk factors	26
995: Enhancing outcomes: Neoadjuvant chemoradiation in locally advanced operable esophageal cancer.	26
3017: SABR of bony oligometastases, 1-year, efficacy, and toxicity analyses from the Bony-M trial	26
2848: Stereotactic body radiotherapy in elderly pancreatic cancer patients: single-institution experience	26
1348: Clinical application of a probabilistic robustness evaluation tool for proton therapy treatments	25
3185: Retrospective analysis of output data for ten linear accelerators at Northern Ireland Cancer Centre	25
940: Implementing plan of the day for cervix cancer: which contouring method and margins to use	25
649: HDR brachytherapy as monotherapy in the treatment of prostate cancer	25
1432: Comparative study of various homogeneity indices in SIB-VMAT planning for head and neck tumors.	25
1127: Analysis of interstitial catheter number and dosimetric parameters in cervical cancer brachytherapy	25
773: FGFR2+ fibroblast-derived BMP5 promoted radioresistance in esophageal carcinoma	25
2119: Comparative Evaluation of 4DCT and 3D T1/T2w MRI in Delineation of Moving Target: A Phantom Study	24
2437: Clinical predictors of late lymphopenia in PCa patients undergoing radical or post-operative WPRT	24
2128: Individual organ dose calculations from CT imaging of Hodgkin lymphoma patients treated with protons	24
1974: Acute Toxicity in a Randomized Trial of MRI-guided Salvage RT for Prostate Cancer in 4 vs. 2 Weeks	24
1463: NG11-2 Phase Ib trial to reduce radiation-induced oral mucositis on patients with head & neck cancer	24
3194: LA-NSCLC: clinical outcomes and comparison of 2-weekly versus 4-weekly durvalumab consolidation	24
70: Developing imaging biomarkers for the incidence of RP in patients with NSCLC who have underlying IPF	24
2999: Craniospinal irradiation in Helical Tomotherapy: Dosimetric analysis and acute toxicity evaluation	24
2238: Efficacy and Safety of Low Dose Radiation Therapy for Alzheimer’s Disease: Phase II Clinical Trial	24
2422: Comparison of the patient movement in thorax treatments with free breathing and DIBH with SGRT	23
780: Proton radiotherapy in meningioma and hemangiopericytoma: a monocentric clinical report	23
285: Metal artifact in MR-based synthetic CT for intracranial radiotherapy: impact on dosimetry and setup	23
735: Patterns of care and outcome of liver SBRT: results from a multicentre national quality project.	23
680: SAPPHIRE - Establishment of Small Animal Proton and PHoton IRradiation Experiments	23
1193: Cytokines modulation by pelvic RT with simultaneous hypofractionated boost in prostate cancer	23
134: The predictive value of Equivalent Uniform Dose (EUD) in Microbeam Radiation Therapy (MRT)	23
479: Field output correction factors of small static field for IBA Razor NanoChamber	23
994: Terminology, Recording, Reporting for Ultra-High Dose Rates: ESTRO Physics of FLASH Workshop update	23
655: FET-PET and MRI integration in the planning process of HGG treated with adjuvant radiochemotherapy	23
444: Sensitivity and specificity evaluation of PerFRACTION in a HALCYON 2.0	23
2681: Management of air in rectum and anal canal during adaptive radiotherapy.	23
3119: Large bicentric study on dosimetric changes during head and neck radiotherapy	23
1856: Radiation therapists implication in research and transversal projects - Experience of Caen Center	22
1329: Development of a Mobile Application to Support Prostate Cancer Patients Undergoing Radiotherapy	22
2060: Stereotactic Body Radiation Therapy (SBRT) for pain control in spinal metastases	22
3123: Stereotactic body radiotherapy for extracranial, intracranial or mixed-pattern oligometastatic NSCLC	22
1086: Urethra-sparing single-dose ablative prostate radiotherapy with real-time motion management	22
2522: Optimal pressure of CPAP for reduction mean heart dose in left-sided breast cancer radiotherapy	21
2581: PET/MR imaging biomarkers of radioresistance in anal cancer patients	21
3078: Enhancing Treatment Quality and Patient Safety: Streamlined Process Using 3D In-Vivo Dosimetry	21
1062: Micro-dissected tumour tissues-on-chip; a tool for translational radiation oncology	21
1043: External validation of automated treatment planning for HDR prostate brachytherapy using BRIGHT	21
1695: Time-resolved analysis of clinical dose metrics for HDR brachytherapy error detection	21
80: Overview of tumour sterilization rates in rectal cancers among treatment modalities; is more better?	21
768: Proton minibeam radiation therapy is a promising approach for re-irradiations	21
2529: ‘Tribrid’ teaching: The optimal model for 21st century clinical oncology education?	21
2769: TRIBBLES1 (TRIB1) pseudokinase- mediated modulation of p53 function through COP1 and/or HDAC1 in GBM	21
2035: Salvage stereotactic radiosurgery after whole brain radiotherapy in non-small cell lung cancer	21
1715: Pathological Phenotypes and Radiation Sensitivity of Airway Stem Cells Derived from COPD Patients.	21

3231: Creating similarly robust plans for different radiotherapy delivery systems	21
1599: Optimization of the comparison metric for EPID in vivo dosimetry of lung treatment	20
385: Teaching and AI-Assistance Improve Organs-At-Risk Contouring for Head-Neck Cancer in a Global Study	20
2803: Treatment outcomes of intra-arterial chemoradiotherapy for oral cavity squamous cell carcinoma.	20
284: Time-dependent diffusion MRI for tumor characterization in biologically adapted radiotherapy	20
1568: Toward multi-institutional Knowledge-Based benchmark for right and left whole breast irradiation	20
1142: Treatment-related parameters and acute toxicity in salvage radiotherapy of prostate cancer	20
2543: Characterization of the oxygen transport variation with dose on a cohort of breast cancer patients	20
1635: In vivo dosimetry - keeping my finger on the pulse	20
2175: SBRT vs SBRT + HDR-boost: a prospective comparative analysis of toxicity, QoL and disease control.	20
1876: On table adaptation in MR Guided prostate cancer treatments. Can RTTs replace the physician?	20
3318: Collaborative research initiatives: Unleashing the potential of RTTs worldwide	20
3046: Factors influencing adaptive radiotherapy and tumor dynamics in cervical cancer treatment	19
90: Delta CT radiomics features predicts prognosis after neoadjuvant chemotherapy in gastric-cancer	19
1749: Dosimetry and survival in unresectable primary HCC patients undergoing resin 90Y SIRT	19
3490: Risk-adapted and response-adapted strategies for stage 3 NSCLC	19
2601: Guidelines-based automatic segmentation improvements	19
771: Hypofractionated dose-escalated salvage RT for macroscopic prostate cancer local recurrence	19
722: Standard versus highly hypofractionated tumor irradiation in LA-NSCLC with durvalumab consolidation	19
3040: Radiotherapy-related quality of life in patients with Gynecological cancer	19
1059: Predictive value of tumor volume change during chemoradiotherapy in non-small cell lung cancer	19
1247: ANTI-TUMOR AND ACUTE TOXICITY OF FRACTIONATED STEREOTACTIC RADIOTHERAPY COMBINED WITH HYPERTHERMIA	19
2605: HDR brachytherapy boost plus EBRT in unfavorable prostate cancer: results in more then 700 patients	19
2019: The Impact of Concurrent Chemotherapy on Stage II Nasopharyngeal Carcinoma	19
3149: The toxicity and value of interstitial brachytherapy boost for high-risk breast cancer patients	19
1442: EBUS-guided fiducial placement for SBRT in mediastinal nodal oligometastases	18
2559: Outcomes of intracranial germ cell tumours treated at a single UK proton centre	18
3470: Quality of life and cosmetic assessment in skin cancer treatment	18
1028: Is volumetric repainting needed to minimize interplay induced dose effects in lung proton therapy?	18
3128: Self-applied photobiomodulation therapy for radiation toxicity in head and neck cancer patients	18
3335: Fairness in radiotherapy data use analysis & outcome modelling	18
511: Enhanced IMPT dose fall-off by optimised integration of Bragg peaks and transmission pencil beams	18
1952: Leveraging hybrid PET/MR imaging to distinguish progression from radionecrosis post-radiosurgery	18
3622: Single-cell analysis of lung responses to radiation injury	18
890: Impact of cumulative cisplatin-dose on distant metastasis after chemoradiation of cervical cancer	18
1096: Classical prognostic factors outperform SUV-max in LACC: an observational study	18
503: A study comparing response for weekly v/s three weekly cisplatin in accelerated CRT for HNSCC	18
2486: Impact of patient specific deep learning OAR segmentation on accumulated online adapted MRgRT dose	18
394: Dosimetric evaluation of synthetic 3DCTs reconstructed from a single x-ray radiograph using CNN	18
3315: Greening our hospitals: circular economy in healthcare & green skills for RTT – What we know?	18
1622: Title: Gamma Knife Radiosurgery for Trigeminal Neuralgia: A review of 59 patients	18
916: Dosimetric characterization of the FLASHKNiFE 10 MeV UHDR beam towards clinical translation	18
1271: Improving breast cancer radiotherapy: determine need for plan adaptation based on corrected CBCTs	18
3093: Derivation of radiomic classifiers for radiotherapy response in locally advanced rectal cancer	18
2797: Initial Clinical and Dosimetric outcomes with TBI planned on Helical Tomotherapy	18
2053: An Italian multi-department study for relative dosimetry in tomotherapy	18
3162: Proton Therapy for Unresectable and Medically Inoperable Locally Advanced Pancreatic Cancer	18
262: Radiation induces Mitochondrial Biogenesis and Cellular Quiescence Exit in PDOX models of pHGG	18
3277: A cyber-attack response plan: How to ensure that patients continue to be treated (correctly)	17
972: Proton therapy for patients with meningioma—Long-term outcomes from ProReg and KiProReg study	17
1060: Validation of a parameterised automated VMAT technique for SIB radiotherapy of head and neck cancer.	17
2428: Radiotherapy or cystectomy in muscle-invasive bladder cancer: Outcomes with two clinical pathways	17
1785: Comparison between Ethos measurements and dosimetric parametres calculated with Acuros XB Beam Model	17
2679: ROLE OF STEREOTACTIC RADIOTHERAPY IN OLIGO-RECURRENCE OF PLEURAL MESOTHELIOMA	17
1603: Early cardiac functional and gene expression markers after irradiation of cardiac substructures	17
159: Measurement of output factor for Cyberknife using scintillation dosimetry and deep learning	17
2932: Oligometastatic liver SABR: clinical outcomes and evaluation of relapse pattern	17
941: Should Varian HyperArc make us re-think how we use conventional linacs for SRS?	17
139: Stereotactic radiosurgery in elderly patients with brain metastases from non-small cell lung cancer	17
335: 0 mm PTV margin to reduce toxicity in MRI-guided RT for favorable intermediate-risk prostate cancer	17
1850: Factors predict Complete Histological Response following neoadjuvant radiotherapy for rectal cancer	17
1979: Predicting radionecrosis following different radiotherapy dose for intracranial meningiomas	17
1639: Robust VMAT dose planning on breast patients and selection of optimization bolus.	17
1689: Double Shell Positioning System versus Thermoplastic Shell For Brain Radiotherapy	17
158: Validation of intrafraction prostate drift corrections on a 1.5T MR-linac using cine-MRI	17
2749: Feasibility of SBRT with CK in the scenario of lung metastases re-RT: monoinstitutional experience.	17
1305: Impact of Abdominal Compression in SBRT for upper abdominal tumors	16
1377: Dose Prediction for Prostate Radiotherapy Planning	16
529: Use of a radar plot to assess cervical HDR brachytherapy plans and correlate with clinical outcomes	16
691: A single-arm confirmatory trial of IMRT alone for early-stage oropharyngeal cancer: JCOG1208	16
1728: Development of a Preclinical X-ray Minibeam Monte Carlo Treatment Planning System using Topas	16
895: Predicting Overall Survival for Patients Who Underwent Adjuvant Chemoradiotherapy for Gastric Cancer	16
3502: Standardising complex treatments like Total Body Irradiation (TBI) and Total Marrow and Lymph node Irradiation (TMLI)	16
1243: Evaluation of organ at risk contours in breast cancer patients: the role of radiation therapist	16
1215: Oligometastatic Mesothelioma treated with Ablative Radiotherapy (OMAR): multi-institutional database	16
2434: The radiobiological principles of low dose radiotherapy for non-cancer diseases	16
1573: Automated audit of planned versus delivered radiotherapy	16
1861: Performance of a heart substructures autocontouring tool after clinical implementation	16
1517: Intramedullary and leptomeningeal-epidural metastases. Outcomes of a rare and ominous condition.	16
2078: Clinical outcome of palliative radiotherapy for oligometastatic and non-oligometastatic lung cancer.	16
552: First-in-human breast imaging study with ultra-low field MRI for compact proton therapy systems	16
2476: Enhancing Patient Education: Assessing radiation therapists' understanding of hospital guidance.	16
2278: Decision aids and treatment regret in patients with localised prostate cancer: a systematic review	16
2981: Inflammatory indexes prognostic value in STS patients treated with preoperative chemoradiation	16
95: Phase Ib trial of Durvalumab plus tremelimumab with particle therapy for advanced HCC: DEPARTURE	16
2752: A phantom study of robust analysis of Lung SBRT BH plan	16
3061: Gut microbiome and gene expression changes during a Phase 1 trial of enadenotucirev and radiotherapy	16
1294: A Multi-Omics Database Using Clinical Trial Data for Rectal Cancer Radiotherapy Outcome Prediction	15
2275: Novel radiation quality metrics significantly increases performance of in vitro RBE proton models	15
2008: A Generative Adversarial Network for Radiotherapy Dose Predictions of Head and Neck Cancers	15
3201: Dosimetric properties of flexible 3D-printed boluses	15
336: Radiation-induced lymphopenia predicts poor survival in HCC patients treated with radiotherapy	15
2284: Comparison of Diffusion-weighted MRI using SPLICE and SS-EPI in Tumors of the Head and Neck.	15
3237: Pulsatile exposure to acid and radiation response in cells resembling oesophageal adenocarcinoma	15
2185: Internal motion variations associated with respiratory phase changes during amplitude gating VMAT	15